View Older Stories

Feb 9, 2026 09:08AM Biogen (BIIB) PT Raised to $233 at RBC Capital

Feb 9, 2026 08:53AM Biogen (BIIB) PT Raised to $177 at Piper Sandler as 'Leqembi Continues to Ramp Well'

Feb 9, 2026 07:51AM 'We Are Getting More Constructive Biogen (BIIB)'; PT Raised to $201 at Bernstein

Feb 9, 2026 07:19AM Biogen (BIIB) PT Raised to $230 at Canaccord Genuity

Feb 9, 2026 07:17AM Biogen (BIIB) PT Raised to $246 at Guggenheim

Feb 9, 2026 06:37AM Biogen (BIIB) PT Raised to $228 at H.C. Wainwright

Feb 9, 2026 05:55AM Baird Reiterates Outperform Rating on Biogen (BIIB)

Feb 6, 2026 02:15PM Biogen (BIIB) PT Raised to $250 at Oppenheimer

Feb 6, 2026 06:45AM Biogen shares rise as Q4 earnings beat expectations, 2026 profit outlook strong

Feb 6, 2026 06:06AM Biogen (BIIB) Tops Q4 EPS by 38c, Beats on Revenue; Offers FY26 EPS Guidance

Feb 6, 2026 02:00AM Biogen earnings preview Q4: set for weaker print, Leqembi outlook in focus

Feb 5, 2026 10:29AM Biogen (BIIB) call put ratio 12 calls to 1 put into quarter results

Feb 5, 2026 06:18AM Biogen (BIIB) call put ratio 2.5 calls to 1 put into quarter results

Feb 4, 2026 11:02AM Biogen (BIIB) call put ratio 1 call to 1.2 puts into quarter results

Feb 4, 2026 07:30AM BIOGEN publishes study results for high-dose nusinersen in Nature Medicine

Feb 3, 2026 07:20AM Biogen (BIIB) PT Lowered to $191 at Bernstein

Jan 27, 2026 06:48AM JPMorgan on Biogen (BIIB) in 2026: 'Watching Pipeline Derisking Through the Year'

Jan 14, 2026 06:07AM Biogen expects $222M charge from research deals in Q4 2025

Jan 13, 2026 12:53PM RBC Capital on Biogen (BIIB): 'Competition from assets such as trontinemab remains years away, and not a threat this decade most likely'

Jan 12, 2026 11:06AM BIOGEN receives EU approval for high dose SPINRAZA for spinal muscular atrophy

Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC

Jan 7, 2026 03:43PM Biogen (BIIB) PT Raised to $207 at Mizuho

Jan 7, 2026 03:06AM UBS Assumes Biogen (BIIB) at Neutral

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 18, 2025 03:11PM RBC: 'We have just confirmed that a recent clinicaltrials.gov listing for a new drug called BIIB145'

Dec 15, 2025 08:44AM Western Digital stock rises after inclusion in Nasdaq-100 Index

Dec 10, 2025 08:20AM HSBC highlights one pharma stock to buy and one to sell for 2026

Dec 10, 2025 02:04AM HSBC Downgrades Biogen (BIIB) to Reduce

Dec 5, 2025 09:01AM Stoke Therapeutics and Biogen present zorevunersen data at epilepsy meeting

Dec 2, 2025 04:41PM Eisai and Biogen present data showing LEQEMBI binding to toxic proteins

Dec 1, 2025 07:31AM Stoke and Biogen to present zorevunersen data at epilepsy conference

Dec 1, 2025 06:53AM UK and US poised to agree zero-tariffs deal on pharmaceuticals - The Times

Nov 24, 2025 08:55AM Biogen to gain from Novo Nordisk Alzheimer’s failure, says Jefferies

Nov 24, 2025 08:47AM Bernstein on Novo's Alzheimer's miss: 'Don't expect Lilly to stay quiet'

Nov 24, 2025 07:30AM Biogen partners with Dayra to develop oral macrocyclic peptides

Nov 17, 2025 07:30AM Stoke and Biogen publish data showing Dravet syndrome severity

Nov 17, 2025 06:02AM Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 6, 2025 07:32AM Stifel lifts Biogen to Buy, sees potential Alzheimer's narrative shift

Nov 6, 2025 05:08AM Stifel Upgrades Biogen (BIIB) to Buy, 'Risk/Reward Shifting Favorably With Clinical Catalysts'

Nov 3, 2025 07:32AM Biogen to present felzartamab data at kidney disease conference

Nov 3, 2025 07:10AM Biogen (BIIB) PT Raised to $157 at Bernstein SocGen Group

Oct 31, 2025 04:55AM Biogen (BIIB) PT Lowered to $250 at Baird

Oct 31, 2025 03:37AM Biogen (BIIB) PT Raised to $185 at Guggenheim

Oct 30, 2025 06:17AM Biogen (BIIB) Tops Q3 EPS by 93c; updates guidance

Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'

Oct 24, 2025 07:31AM Biogen licenses oral drug from Vanqua Bio for $70 million upfront

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 14, 2025 04:21PM Biogen expects $2 million charge in third quarter 2025

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

View Older Stories